MBX Biosciences, Inc.
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -5.38% | 401.36% | -21.41% | -12.84% | -- |
Total Receivables | -20.51% | 423.17% | -17.59% | -4.33% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 51.47% | -23.05% | 55.56% | -17.73% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -4.18% | 246.28% | 44.05% | 26.32% | -- |
Total Current Assets | -4.94% | 378.17% | -19.11% | -12.90% | -- |
|
|||||
Total Current Assets | -4.94% | 378.17% | -19.11% | -12.90% | -- |
Net Property, Plant & Equipment | 1.61% | -7.74% | 45.34% | 32.33% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -98.22% | 60.76% | 3,386.00% | -- |
Total Assets | -4.91% | 349.10% | -16.51% | -10.53% | -- |
|
|||||
Total Accounts Payable | 6.66% | 55.29% | 0.78% | 129.76% | -- |
Total Accrued Expenses | -3.60% | 19.46% | 105.51% | -1.64% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.01% | 2.47% | 3.18% | 2.61% | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 1.20% | 33.20% | 43.93% | 45.08% | -- |
|
|||||
Total Current Liabilities | 1.20% | 33.20% | 43.93% | 45.08% | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -49.43% | -32.56% | -24.56% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -38.24% | -45.60% | -32.43% | -4.64% | -- |
Total Liabilities | 0.55% | 31.18% | 39.93% | 40.06% | -- |
|
|||||
Common Stock & APIC | 0.44% | 6,556.19% | 21.14% | 59.61% | -- |
Retained Earnings | -12.78% | -17.48% | -18.04% | -16.32% | -- |
Treasury Stock & Other | -48.11% | 806.67% | -400.00% | -105.00% | -- |
Total Common Equity | -5.13% | 377.23% | -17.87% | -14.60% | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | 0.00% | 0.00% | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | 0.00% | 0.00% | -- |
|
|||||
Total Common Equity | -5.13% | 377.23% | -17.87% | -14.60% | -- |
Total Preferred Equity | -- | -- | 0.00% | 0.00% | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -5.13% | 398.18% | -21.41% | -13.24% | -- |
|